logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

Namaste-Technologies-Inc.-TSXV-N

Namaste Announces Strategic Investment in Kief Cannabis and 35% ROFR on Supply

Nov 26, 2018

Mexico Approves the Commercial Importation of Cannabis Products

Nov 23, 2018

Cannabis, Life Science

With New HQ, Ipsen to Rapidly Expand North American Presence

Nov 23, 2018

Life Science

OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer

Nov 23, 2018

Life Science

Graph Blockchain Limited(CSE:GBLC)

Beleave Announces Release Date of Second Quarter 2018 Results and Conference Call

Nov 23, 2018

Life Science

Merck announces innovative MS treatment MAVENCLAD® (Cladribine Tablets) selected for rapid uptake by the Accelerated Access Collaborative,默克公司多发性硬化症治疗药物Mavenclad®(克拉屈滨片)获AAC认可

Merck announces innovative MS treatment MAVENCLAD® (Cladribine Tablets) selected for rapid uptake by the Accelerated Access Collaborative

Nov 23, 2018

Life Science

Milestone Scientific Inc. (NYSE America: MLSS)

Milestone Scientific Announces Recent Presentations Featuring The Wand® STA

Nov 23, 2018

Life Science

Namaste-Technologies-Inc.-TSXV-N

Cannmart Signs Product Acquisition Agreement with Weed Me Inc.

Nov 23, 2018

Life Science

Novartis gets European approval for sight therapy Luxturna

Nov 22, 2018

Life Science

China’s iKang Healthcare to Introduce AI Technology, Founder Says

Nov 22, 2018

Life Science

WuXi Biologics Commenced Construction of 1.6 million sq. ft. Biologics Innovation Center in Shanghai

Nov 22, 2018

Life Science

IMBiotechnologies Ltd. Receives Health Canada Approval for a New Biodegradable Embolic Agent-IMBiotechnologies Ltd.的可生物降解栓塞剂Ekobi™获加拿大卫生部批准

IMBiotechnologies Ltd. Receives Health Canada Approval for a New Biodegradable Embolic Agent

Nov 21, 2018

Life Science

Cedrus Investments Signed Cooperation Agreement with Sinopharm Nutraceuticals Industrial (Shanghai) on 16th November 2018-赛德思投资与国药健康实业(上海)有限公司签署合作协议

Cedrus Investments Signed Cooperation Agreement with Sinopharm Nutraceuticals Industrial (Shanghai) on 16th November 2018

Nov 21, 2018

Life Science

HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Research Collaboration-中国成都先导与美国Biogen签订基于DNA编码化合物库技术的新药研发合作协议

HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Research Collaboration

Nov 21, 2018

Life Science

Namaste-Technologies-Inc.-TSXV-N

Cannmart announces asset purchase agreement with Buds2go.ca

Nov 21, 2018

Life Science

N.J. Recreational Marijuana Bill About to Take Major Step Ahead

Nov 20, 2018

Cannabis, Life Science

Sinclair Pharma Announces Acquisition of the Company by Huadong Medicine Co., Ltd

Nov 20, 2018

Life Science

Alma, a Sisram Medical Company, Announces the Opening of a Direct Operation in Israel Following the Acquisition of Its Israeli Distributor

Nov 20, 2018

Life Science

  • ‹‹ Previous
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada